Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany.
Department of Hematology and Oncology, Federal Armed Forces Hospital Ulm, Ulm, Germany.
Blood Adv. 2021 Dec 14;5(23):5220-5225. doi: 10.1182/bloodadvances.2021004635.
The recent characterization of a group of non-MYC rearranged aggressive B-cell lymphomas, resembling Burkitt lymphoma (BL), characteristically harboring a telomeric 11q loss or combined 11q proximal gains/loss pattern has led to the introduction of the provisional entity of Burkitt-like lymphoma with 11q aberration (BLL-11q). Prompted by the discovery of a telomeric 11q loss in an HIV+ high-grade B-cell lymphoma patient, we investigated an extended cohort of aggressive B-cell lymphomas, enriched for cases with histopathological features intermediate between DLBCL and BL, including double- and triple-hit lymphomas (n = 47), for 11q loss/combined 11q proximal gains/loss pattern by fluorescence in situ hybridization. We provide first evidence that 11q aberrations can be found in both BLL in the context of an underlying HIV infection as well as in high-grade B-cell lymphomas with MYC, BCL2, and/or BCL6 rearrangements. We therefore propose that the clinicopathological spectrum of malignancies carrying this aberration may be broader than previously assumed.
最近对一组非 MYC 重排的侵袭性 B 细胞淋巴瘤进行了特征描述,这些淋巴瘤类似于 Burkitt 淋巴瘤 (BL),其特征是存在端粒 11q 缺失或联合 11q 近端获得/缺失模式,这导致了具有 11q 异常的暂定实体 Burkitt 样淋巴瘤 (BLL-11q) 的引入。在一名 HIV+高级别 B 细胞淋巴瘤患者中发现端粒 11q 缺失后,我们通过荧光原位杂交对一组侵袭性 B 细胞淋巴瘤进行了扩展队列研究,这些淋巴瘤富含具有介于 DLBCL 和 BL 之间的组织病理学特征的病例,包括双打击和三打击淋巴瘤(n=47),以检测 11q 缺失/联合 11q 近端获得/缺失模式。我们首次提供了证据,表明 11q 异常可在 HIV 感染背景下的 BLL 以及具有 MYC、BCL2 和/或 BCL6 重排的高级别 B 细胞淋巴瘤中发现。因此,我们提出携带这种异常的恶性肿瘤的临床病理谱可能比以前假设的更广泛。